William D. Turner, Chief Regulatory Officer at Vera Therapeutics, Inc. (VERA), sold 10,000 shares at $50.08 ($501K) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($501k) by Chief Regulatory Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VERA | SELL | 2025-12-04 | $400K | — | Filing → |
| SRRA | SELL | 2022-04-07 | $477K | — | Filing → |
| SRRA | SELL | 2022-03-22 | $4K | — | Filing → |